| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Experimental Oncology 1, Centro di Riferimento Oncologico, via Pedemontana Occidentale 12, 33081 Aviano (PN) [D. G., R. M., S. P., T. V., M. B.], and Divisions of Otorhinolaryngology [L. B.] and Pathology [S. S.], Pordenone City Hospital, 33170 Pordenone, Italy
The deregulation of several cell cycle-related genes participates in neoplastic transformation. Cell cycle progression is driven by cyclin-dependent kinases, which are positively regulated by association with cyclins and negatively regulated by binding to inhibitory subunits. The activity of cyclin-dependent kinases is also regulated by the phosphorylation status, which is controlled by the antagonistic action of weel kinase and CDC25 phosphatases. Three CDC25 genes are present in human cells: CDC25A, CDC25B, and CDC25C. These three genes function at different phases of the cell cycle. Whereas CDC25A and CDC25B are expressed throughout the cell cycle, with peak expression in G1 for CDC25A and in both G1-S-phase and G2 for CDC25B, CDC25C is predominantly expressed in G2. Several lines of evidence suggest a role for CDC25s as oncogenes. CDC25A and CDC25B cooperate with Ha-ras or loss of Rb1 in the oncogenic transformation of rodent fibroblasts. Moreover, they are transcriptional targets of c-myc, and CDC25A in particular plays an important role as a mediator of myc functions. On the basis of the evidence that CDC25 phosphatases can act as oncogenes, we analyzed the expression of CDC25A, CDC25B, and CDC25C genes in 20 squamous cell carcinomas of the head and neck by quantitative reverse transcription-PCR. Our results show that whereas CDC25C is expressed at a low level with no relevant differences between neoplastic tissue and normal mucosa, CDC25A and CDC25B are overexpressed in a large fraction of tumors.
1 Supported in part by a grant from the Italian Association for Cancer Research.
2 To whom requests for reprints should be addressed.
Received 3/18/97. Accepted 4/30/97.
This article has been cited by other articles:
|
|
 |
|
  Z.-R. Yuan and Y. Shi Chloramphenicol Induces Abnormal Differentiation and Inhibits Apoptosis in Activated T Cells Cancer Res., June 15, 2008; 68(12): 4875 - 4881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Levesque, A. A. Fanous, A. Poh, and A. Eastman Defective p53 signaling in p53 wild-type tumors attenuates p21waf1 induction and cyclin B repression rendering them sensitive to Chk1 inhibitors that abrogate DNA damage-induced S and G2 arrest Mol. Cancer Ther., February 1, 2008; 7(2): 252 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Srivastava, P. Bansal, T. Oguri, J. S. Lazo, and S. V. Singh Cell Division Cycle 25B Phosphatase Is Essential for Benzo(a)Pyrene-7,8-Diol-9,10-Epoxide Induced Neoplastic Transformation Cancer Res., October 1, 2007; 67(19): 9150 - 9157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Ray, Y. Terao, D. Nimbalkar, H. Hirai, E. C. Osmundson, X. Zou, R. Franks, K. Christov, and H. Kiyokawa Hemizygous Disruption of Cdc25A Inhibits Cellular Transformation and Mammary Tumorigenesis in Mice Cancer Res., July 15, 2007; 67(14): 6605 - 6611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Ray, Y. Terao, P. G. Fuhrken, Z.-Q. Ma, F. J. DeMayo, K. Christov, N. A. Heerema, R. Franks, S. Y. Tsai, E. T. Papoutsakis, et al. Deregulated CDC25A Expression Promotes Mammary Tumorigenesis with Genomic Instability Cancer Res., February 1, 2007; 67(3): 984 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kar, M. Wang, W. Yao, C. J. Michejda, and B. I. Carr PM-20, a novel inhibitor of Cdc25A, induces extracellular signal-regulated kinase 1/2 phosphorylation and inhibits hepatocellular carcinoma growth in vitro and in vivo. Mol. Cancer Ther., June 1, 2006; 5(6): 1511 - 1519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ozen and M. Ittmann Increased Expression and Activity of CDC25C Phosphatase and an Alternatively Spliced Variant in Prostate Cancer Clin. Cancer Res., July 1, 2005; 11(13): 4701 - 4706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Ray, Y. Terao, D. Nimbalkar, L.-H. Chu, M. Donzelli, T. Tsutsui, X. Zou, A. K. Ghosh, J. Varga, G. F. Draetta, et al. Transforming Growth Factor {beta} Facilitates {beta}-TrCP-Mediated Degradation of Cdc25A in a Smad3-Dependent Manner Mol. Cell. Biol., April 15, 2005; 25(8): 3338 - 3347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-S. Chen, C. E. Ryan, and H. Piwnica-Worms Chk1 Kinase Negatively Regulates Mitotic Function of Cdc25A Phosphatase through 14-3-3 Binding Mol. Cell. Biol., November 1, 2003; 23(21): 7488 - 7497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Scrivens, M. A. Alaoui-Jamali, G. Giannini, T. Wang, M. Loignon, G. Batist, and V. A. Sandor Cdc25A-inhibitory properties and antineoplastic activity of bisperoxovanadium analogues Mol. Cancer Ther., October 1, 2003; 2(10): 1053 - 1059. [Abstract] [Full Text]
|
|
|
|
|
|
X. Xu, H. Yamamoto, M. Sakon, M. Yasui, C. Y. Ngan, H. Fukunaga, T. Morita, M. Ogawa, H. Nagano, S. Nakamori, et al. Overexpression of CDC25A Phosphatase Is Associated with Hypergrowth Activity and Poor Prognosis of Human Hepatocellular Carcinomas Clin. Cancer Res., May 1, 2003; 9(5): 1764 - 1772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Oguri, S. V. Singh, K. Nemoto, and J. S. Lazo The Carcinogen (7R,8S)-Dihydroxy-(9S,10R)-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene Induces Cdc25B Expression in Human Bronchial and Lung Cancer Cells Cancer Res., February 15, 2003; 63(4): 771 - 775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Li and F. H. Sarkar Gene Expression Profiles of Genistein-Treated PC3 Prostate Cancer Cells J. Nutr., December 1, 2002; 132(12): 3623 - 3631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Pu, A. A. Amoscato, M. E. Bier, and J. S. Lazo Dual G1 and G2 Phase Inhibition by a Novel, Selective Cdc25 Inhibitor 7-Chloro-6-(2-morpholin-4-ylethylamino)- quinoline-5,8-dione J. Biol. Chem., November 27, 2002; 277(49): 46877 - 46885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Melkun, M. Pilione, and R. F. Paulson A naturally occurring point substitution in Cdc25A, and not Fv2/Stk, is associated with altered cell-cycle status of early erythroid progenitor cells Blood, November 15, 2002; 100(10): 3804 - 3811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. McGregor, A. Muntoni, J. Fleming, J. Brown, D. H. Felix, D. G. MacDonald, E. K. Parkinson, and P. R. Harrison Molecular Changes Associated with Oral Dysplasia Progression and Acquisition of Immortality: Potential for Its Reversal by 5-Azacytidine Cancer Res., August 15, 2002; 62(16): 4757 - 4766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-Q. Ma, Z. Liu, E. S. W. Ngan, and S. Y. Tsai Cdc25B Functions as a Novel Coactivator for the Steroid Receptors Mol. Cell. Biol., December 1, 2001; 21(23): 8056 - 8067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. C. Hu, K. Y. Lam, S. Law, J. Wong, and G. Srivastava Identification of Differentially Expressed Genes in Esophageal Squamous Cell Carcinoma (ESCC) by cDNA Expression Array: Overexpression of Fra-1, Neogenin, Id-1, and CDC25B Genes in ESCC Clin. Cancer Res., August 1, 2001; 7(8): 2213 - 2221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zou, T. Tsutsui, D. Ray, J. F. Blomquist, H. Ichijo, D. S. Ucker, and H. Kiyokawa The Cell Cycle-Regulatory CDC25A Phosphatase Inhibits Apoptosis Signal-Regulating Kinase 1 Mol. Cell. Biol., July 15, 2001; 21(14): 4818 - 4828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-S. Chen, J. Hurov, L. S. White, T. Woodford-Thomas, and H. Piwnica-Worms Absence of Apparent Phenotype in Mice Lacking Cdc25C Protein Phosphatase Mol. Cell. Biol., June 15, 2001; 21(12): 3853 - 3861. [Abstract] [Full Text]
|
|
|
|
|
|
H. Miyata, Y. Doki, H. Yamamoto, K. Kishi, H. Takemoto, Y. Fujiwara, T. Yasuda, M. Yano, M. Inoue, H. Shiozaki, et al. Overexpression of CDC25B Overrides Radiation-induced G2-M Arrest and Results in Increased Apoptosis in Esophageal Cancer Cells Cancer Res., April 1, 2001; 61(7): 3188 - 3193. [Abstract] [Full Text]
|
|
|
|
|
|
H. Miyata, Y. Doki, H. Shiozaki, M. Inoue, M. Yano, Y. Fujiwara, H. Yamamoto, K. Nishioka, K. Kishi, and M. Monden CDC25B and p53 Are Independently Implicated in Radiation Sensitivity for Human Esophageal Cancers Clin. Cancer Res., December 1, 2000; 6(12): 4859 - 4865. [Abstract] [Full Text]
|
|
|
|
|
|
I. Takemasa, H. Yamamoto, M. Sekimoto, M. Ohue, S. Noura, Y. Miyake, T. Matsumoto, T. Aihara, N. Tomita, Y. Tamaki, et al. Overexpression of CDC25B Phosphatase as a Novel Marker of Poor Prognosis of Human Colorectal Carcinoma Cancer Res., June 1, 2000; 60(11): 3043 - 3050. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I.B. Weinstein Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis Carcinogenesis, May 1, 2000; 21(5): 857 - 864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. Lee, C. L. Reimer, L. Fang, M. L. Iruela-Arispe, and S. A. Aaronson Overexpression of Kinase-Associated Phosphatase (KAP) in Breast and Prostate Cancer and Inhibition of the Transformed Phenotype by Antisense KAP Expression Mol. Cell. Biol., March 1, 2000; 20(5): 1723 - 1732. [Abstract] [Full Text]
|
|
|
|
|
|
K. Tamura, E. C. Southwick, J. Kerns, K. Rosi, B. I. Carr, C. Wilcox, and J. S. Lazo Cdc25 Inhibition and Cell Cycle Arrest by a Synthetic Thioalkyl Vitamin K Analogue Cancer Res., March 1, 2000; 60(5): 1317 - 1325. [Abstract] [Full Text]
|
|
|
|
|
|
T. Mochizuki, C. Kitanaka, K. Noguchi, T. Muramatsu, A. Asai, and Y. Kuchino Physical and Functional Interactions between Pim-1 Kinase and Cdc25A Phosphatase. IMPLICATIONS FOR THE Pim-1-MEDIATED ACTIVATION OF THE c-Myc SIGNALING PATHWAY J. Biol. Chem., June 25, 1999; 274(26): 18659 - 18666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. K. Naeger, E. C. Goodwin, E.-S. Hwang, R. A. DeFilippis, H. Zhang, and D. DiMaio Bovine Papillomavirus E2 Protein Activates a Complex Growth-inhibitory Program in p53-negative HT-3 Cervical Carcinoma Cells that Includes Repression of Cyclin A and cdc25A Phosphatase Genes and Accumulation of Hypophosphorylated Retinoblastoma Protein Cell Growth Differ., June 1, 1999; 10(6): 413 - 422. [Abstract] [Full Text]
|
|
|
|
|
|
K. Korner, V. Jerome, T. Schmidt, and R. Muller Cell Cycle Regulation of the Murine cdc25B Promoter. ESSENTIAL ROLE FOR NUCLEAR FACTOR-Y AND A PROXIMAL REPRESSOR ELEMENT J. Biol. Chem., March 23, 2001; 276(13): 9662 - 9669. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
